InvestorsHub Logo
Followers 0
Posts 79
Boards Moderated 0
Alias Born 02/09/2021

Re: None

Tuesday, 11/16/2021 11:56:40 AM

Tuesday, November 16, 2021 11:56:40 AM

Post# of 547
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan.
.
"The market for treating aging disorders and extending healthy lifespan is expected to be at least $600 billion by 2025..according to a major investment bank. TNF-a blockers are the most prescribed drugs by revenue, a global market of about $40 billion per year, and according to Nature Aging journal...a slowdown in aging that would increase life expectancy by one year is worth $38 trillion and by 10 years is worth $367 trillion."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMD News